Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001208343 | SCV001379724 | likely pathogenic | Familial hypocalciuric hypercalcemia; Autosomal dominant hypocalcemia 1 | 2019-11-13 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant has been reported to affect CASR protein function (PMID: 27434672). This variant has been observed to segregate with familial hypocalciuric hypercalcemia in a family (PMID: 11762699). Also, the variant has been identified in several individuals with clinical features of familial hypocalciuric hypercalcemia (PMID: 16491288). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with glutamic acid at codon 557 of the CASR protein (p.Gly557Glu). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and glutamic acid. |
Bioscientia Institut fuer Medizinische Diagnostik Gmb |
RCV001030007 | SCV001192810 | pathogenic | Familial hypocalciuric hypercalcemia 1 | 2019-11-08 | no assertion criteria provided | clinical testing |